Acquired FXIII inhibitor: Patient characteristics and treatment outcome, a case series in Taiwan
2020 · Journal of the Formosan Medical Association · 6 citations
https://doi.org/10.1016/j.jfma.2020.05.032
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
276
Citations
8
h-index
8
i10-index
Ching‐Yeh Lin is an academic researcher from Taipei Tzu Chi Hospital. The author has contributed to research in topics: Hemophilia Treatment and Research & Platelet Disorders and Treatments & Venous Thromboembolism Diagnosis and Management. The author has an h-index of 8, co-authored 28 publications.
ORCID: 0000-0002-4371-974Xhttps://doi.org/10.1016/j.jfma.2020.05.032
https://doi.org/10.1016/j.jfma.2022.11.017
https://doi.org/10.1016/j.jiph.2025.102989
Click to start Chat